The evaluation of the possible effect of positive end expiratory pressure (PEEP) on pharmacokinetics of phenytoin in patients with acute brain injury under mechanical ventilation

Daru

Volumn 13, Issue 2, 2005, Pages 74-81

  Hadidi, Elham ^a   Mojtahedzadeh, Mojtaba ^a   Rouini, Mohammad Reza ^a   Eftekhar, Behzad ^b   Abdollahi, Mohammad ^c   Najafi, Atabak ^b   Khajavi, Mohammad Reza ^b   Rezaee, Saeed ^d   Ghaffari, Reza ^b   Afshar, Minoo ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute brain injury; PEEP; Pharmacokinetic; Phenytoin

Indexed keywords

ANTICONVULSIVE AGENT; CHLORAMPHENICOL; CIMETIDINE; DEXAMETHASONE; PHENOBARBITAL; PHENYTOIN;

ACUTE DISEASE; ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; BRAIN INJURY; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG METABOLISM; FEMALE; GLASGOW COMA SCALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MICHAELIS MENTEN KINETICS; POSITIVE END EXPIRATORY PRESSURE; SEIZURE; STROKE; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 24744443518     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Arboix A, Garcia-Eroles L, Massons JB, Oliveres M, Comes E. Predictive factors of early seizures after acute cerebrovascular disease. Stroke 1997; 28:1590-1594.
2. Kilpatrick CJ, Davis SM, Tress BM, Rossiter SC, Hopper JL, Vandendriesen ML. Epileptic seizures in acute stroke. Arch Neurol 1990; 47:157-160.
3. Giroud M, Gras P, Fayolle H, Andre N, Soichot P, Dumas R. Early seizures after acute stroke: a study of 1640 cases. Epilepsia 1994; 35:959-964.
4. So EL, Annegers JF, Hauser WA, O'Brien PC, Whisnant JP. Population-based study of seizure disorders after cerebral infarction. Neurology 1996; 46:350-355.
5. Hernandez TD. Preventing post-traumatic epilepsy after brain injury: weighing the costs and benefits of anticonvulsant prophylaxis. Tips 1997; 18:59-62.
6. Broderick JP, Adams HP, Barsan W, Feinberg W, Feldmann E, Grotta J, Kase C, Krieger D, Meyberg M, Tilley B, Zabramski JM, Zuccarello M. Guidelines for the management of spontaneous intracerebral hemorrhage. A statement for healthcare professionals from special writinggroup of the Stroke Council, American Heart Association. Stroke 1999; 30:905-915.
7. Ferro JM, Pinto F. Poststroke epilepsy: epidemiology, pathophysiology, and management. Drugs Aging 2004; 21:639-653.
8. Demling R, Riessen R. Pulmonary dysfunction after cerebral injury. Crit Care Med 1990; 18:768-774.
9. Meyer SA, Copeland D, Bernardini GL, Boden-Albala B, Lennihan L, Kossoff S, Sacco RL. Cost and outcome of mechanical ventilation for life-threatening stroke. Stroke 2000; 31:2346-2353.
10. Moor FA, Haenel JB. Ventilatory strategies for acute respiratory failure. Am J Surg 1997; 173:53-56.
11. Esteban A, Anzueto A, Alia I, Gordo F, Apesteguia C, Palizas F, Cide D, Goldwaser R, Soto L, Bugedo G, Rodrigo C, Pimentel J, Raimondi G, Tobin MJ. How is mechanical ventilation employed in the intensive care unit? An international utilization review. Am J Respir Crit Care Med 2000; 161:1450-1458.
12. Smith PK, Tyson GS Jr, Hammon JW Jr, Olsen CO, Hopkins RA, Maier GW, Sabiston DC Jr, Rankin JS. Cardiovascular effects of ventilation with positive expiratory airway pressure. Ann Surg 1982; 195:121-130.
13. Steinhoff HH, Samodelov LF, Trampisch HL, Falk KJ. Cardiac afferents and the renal response to positive pressure ventilation in the dog. Intensive Care Med 1986; 12:147-152.
14. Berry AJ. Respiratory support and renal function. Anesthesiology 1981; 55:655-667.
15. Johnson EE, Hedley-Whyte J. Continuous positive pressure ventilation and portal blood flow in dogs with pulmonary edema. J Appl Physiol 1972; 33:385-389.
16. Winso O, Biber B, Gustavsson B, Holm C, Milsom I, Niemand D. Portal blood flow in man during graded positive end-expiratory pressure ventilation. Intensive Care Med 1986; 12:80-85.
17. Matuschak GM, Pinsky MR, Rogers RM. Effects of positive end-expiratory pressure on hepatic flow and performance. J Appl Physiol 1987; 62:1377-1383.
18. Perkins MW, Dasta JF, DeHaven B. The physiological implications of mechanical ventilation on pharmacokinetics. Drug Intel Clin Pharm 1989; 23:316-323.
19. Richard C, Berdeaux A, Delion F, Riou B, Rimailho A, Giudicelli JF, Auzepy P. Effect of mechanical ventilation on hepatic drug pharmacokinetics. Chest 1986; 90:837-841.
20. Lugo G, Castaneda-Hernandez G. Relationship between hemodynamic and vital support measures and pharmacokinetic variability of Amikacin in critically ill patients with sepsis. Crit Care Med 1997; 25:806-811.
21. Hadavand N, Mojtahedzadeh M, Sadray S, Shariat Moharreri R, Shafaghi B, Khajavi MR, Salary P. Pharmacokinetic behavior of Theophylline following PEEP in critically ill patients with acute lung injury. Ir J Pharmaceut Res 2004; 1:35-40.
22. Angus PW, Morgan DJ, Smallwood RA. Hypoxia and hepatic drug metabolism-clinical implications. Aliment Pharmacol Ther 1990; 4:213-225.
23. Elliott SL, Morgan DJ, Angus PW, Ghabrial H, Watson RG, Smallwood RA. The effect of hypoxia on propranolol clearance during antegrade and retrograde flow in the isolated perfused rat liver preparation. Biochem Pharmacol 1993; 45:573-578.
24. Hickey PL, Angus PW, McLean AJ, Morgan DJ. Oxygen supplementation restores theophylline clearance to normal in cirrhotic rats. Gastroenterology 1995; 108:1504-1509.
25. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13:818-829.
26. rd ed. Vanccouver, WA: Applied Therapeutics; 1992. p. 1-44.
27. Anderson GD, Pak C, Doane KW, Griffy KG, Temkin NR, Wilensky AJ, Winn HR. Reversed winter-tozer equation for normalized phenytoin concentrations in trauma and elderly patients with hypoalbuminemia. Ann Pharmacother 1997; 31:279-284.
28. Mlynarek ME, Peterson EL, Zarowitz B. Predicting unbound phenytoin concentrations in the critically ill neurosurgical patient. Ann Pharmacother 1996; 30:219-223.
29. Triginer C, Izquierdo Y, Fernandez R, Torrent J, Benito S, Net A, Jane F. Changes in gentamicin pharmacokinetics profiles induced by mechanical ventilation. Eur J Clin Pharmacol 1991; 40:297-302.
30. Dhainaut JF, Devaux JY, Monsallier JF, Brunei F, Villemant D, Hyughebaret MF. Mechanism of decreased left ventricular preload during continuous positive pressure ventilation in ARDS. Chest 1986; 90:74-80.
31. Jardin F, Farcot JC, Boisante L, Curien N, Margairaz A, Bourdarias JP. Influence of positive end-expiratory pressure on left ventricular performance. N Engl J Med 1981; 304:387-392.
32. Schuster HP. Hemodynamic effects of positive pressure breathing. Klin Wochenschr 1984; 62:56-64.
33. Dorinsky PM, Hamlin RL, Gadek JE. Alterations in regional blood flow during positive end-expiratory pressure ventilation. Crit Care Med 1987; 15:106-113.
34. Johnson DJ, Johannigman JA, Branson RD, Davis K Jr, Hurst JM. The effect of low dose dopamine on gut hemodynamics during PEEP ventilation for acute lung injury. J Surg Res 1991; 50:344-349.
35. Sha M, Saito Y, Yokoyama K, Sawa T, Amaha K. Effects of continuous positive-pressure ventilation on hepatic blood flow and intrahepatic oxygen delivery in dogs. Crit Care Med 1987; 15:1040-1043.
36. Bonnet F, Richard C, Glaser P, Lafay M, Guesde R. Changes in hepatic flow induced by continuous positive pressure ventilation in critically ill patients. Crit Care Med 1982; 10:703-705
37. Lee RDH, Choe E, Flint L, Steinberg S. Neither dopamine nor dobutamine corrects mesenteric blood flow depression caused by positive end-expiratory pressure in arat model of acute lung injury. Crit Care Med 1998; 26:1875-1880.